Advanced search
Publication Cover
OncoImmunology Volume 3, 2014 - Issue 2
Submit an article Journal homepage
585
Views
9
CrossRef citations to date
0
Altmetric
Author's View

Toll-like receptor genetic variants and colorectal cancer

Alexander NR Weber Interfaculty Institute for Cell Biology; Department of Immunology; University of Tübingen; Tübingen, GermanyCorrespondence[email protected] [email protected]
&
Asta Försti Division of Molecular Genetic Epidemiology; German Cancer Research Center (DKFZ); Heidelberg, Germany; Center for Primary Health Care Research; Clinical Research Center; Lund University; Malmö, SwedenCorrespondence[email protected] [email protected]
Article: e27763 | Received 07 Jan 2014, Accepted 08 Jan 2014, Published online: 10 Jan 2014

References

  • Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011; 61:69 - 90; http://dx.doi.org/10.3322/caac.20107; PMID: 21296855
  • Abreu MT. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol 2010; 10:131 - 44; http://dx.doi.org/10.1038/nri2707; PMID: 20098461
  • Pagès F, Galon J, Fridman WH. The essential role of the in situ immune reaction in human colorectal cancer. J Leukoc Biol 2008; 84:981 - 7; http://dx.doi.org/10.1189/jlb.1107773; PMID: 18559950
  • Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 2011; 34:637 - 50; http://dx.doi.org/10.1016/j.immuni.2011.05.006; PMID: 21616434
  • Klimosch SN, Försti A, Eckert J, Knezevic J, Bevier M, von Schönfels W, Heits N, Walter J, Hinz S, Lascorz J, et al. Functional TLR5 genetic variants affect human colorectal cancer survival. Cancer Res 2013; 73:7232 - 42; http://dx.doi.org/10.1158/0008-5472.CAN-13-1746; PMID: 24154872
  • Castro FA, Försti A, Buch S, Kalthoff H, Krauss C, Bauer M, Egberts J, Schniewind B, Broering DC, Schreiber S, et al. TLR-3 polymorphism is an independent prognostic marker for stage II colorectal cancer. Eur J Cancer 2011; 47:1203 - 10; http://dx.doi.org/10.1016/j.ejca.2010.12.011; PMID: 21239167
  • Waldner MJ, Foersch S, Neurath MF. Interleukin-6--a key regulator of colorectal cancer development. Int J Biol Sci 2012; 8:1248 - 53; http://dx.doi.org/10.7150/ijbs.4614; PMID: 23136553
  • Grossman SR, Andersen KG, Shlyakhter I, Tabrizi S, Winnicki S, Yen A, Park DJ, Griesemer D, Karlsson EK, Wong SH, et al, 1000 Genomes Project. Identifying recent adaptations in large-scale genomic data. Cell 2013; 152:703 - 13; http://dx.doi.org/10.1016/j.cell.2013.01.035; PMID: 23415221
  • Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, Srinivasan S, Sitaraman SV, Knight R, Ley RE, Gewirtz AT. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 2010; 328:228 - 31; http://dx.doi.org/10.1126/science.1179721; PMID: 20203013
  • Brenner H, Altenhofen L, Hoffmeister M. Eight years of colonoscopic bowel cancer screening in Germany: initial findings and projections. Dtsch Arztebl Int 2010; 107:753 - 9; PMID: 21085544

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.